Varex Imaging Corp (VREX)
11.92
+0.12
(+1.02%)
USD |
NASDAQ |
Sep 27, 16:00
11.92
0.00 (0.00%)
After-Hours: 20:00
Varex Imaging SG&A Expense (Annual): 128.40M for Sept. 30, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 128.40M |
| September 30, 2022 | 118.30M |
| September 30, 2021 | 125.50M |
| September 30, 2020 | 142.20M |
| September 30, 2019 | 128.10M |
| September 30, 2018 | 123.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 102.50M |
| September 30, 2016 | 85.80M |
| September 30, 2015 | 72.70M |
| September 30, 2014 | 62.60M |
| September 30, 2013 | 63.40M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
118.30M
Minimum
2022
142.20M
Maximum
2020
128.50M
Average
128.10M
Median
2019
SG&A Expense (Annual) Benchmarks
| Hologic Inc | 987.60M |
| Nuwellis Inc | 17.19M |
| Quanterix Corp | 93.95M |
| Inspire Medical Systems Inc | 451.96M |
| Bio-Rad Laboratories Inc | 841.72M |